Nevada Coalition for Psychedelic Medicines (EIN 923319884) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2023

Legal Domicile

Principal Officer

Catherine Cotter

Phone

7752507973

Tax Period

2024-01-01 to 2024-12-31

Nevada Coalition for Psychedelic Medicines, founded in 2023, is a small nonprofit in the Mental Health sector that reported $296K in total revenue in fiscal year 2024. Revenue surged 1097% from the prior year, signaling strong growth momentum. The organization ran a surplus of $105K, a strong 35% operating margin.

Mission

To educate and advocate for psychedelic-assisted therapy to save lives and improve mental health

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $296,243

Program Service Revenue $106

Investment Income $4

Other Revenue $0

TOTAL REVENUE $296,353

Expense Breakdown

Grants Paid $0

Salaries & Benefits $127,478

Fundraising Expenses $36,872

Program Expenses $136,981

Other Expenses $64,330

TOTAL EXPENSES $191,808

Year-over-Year Comparison

	2024	2023	Change
Revenue	$296,353	$24,751	+11.0%
Expenses	$191,808	$21,210	+8.0%
Net Income	$104,545	$3,541	+28.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$136,000

Total Directors

$136,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Eric Anderson	Secretary	1.00	Officer Director	$0	$0	$0
Catherine Cotter	Executive Director/Treasurer	40.00	Officer Director	$59,000	$0	$59,000
Jonathan Dalton	CEO/President	40.00	Officer Director	$77,000	$0	$77,000
Greg Rea	Director (Until Jan '24)	1.00	Director	$0	$0	$0
Tory Clark	Director (Until Jan '24)	1.00	Director	$0	$0	$0
Justin Van Pelt	Director (Until Jan '24)	1.00	Director	$0	$0	$0
Bryan Lang	Director	1.00	Director	$0	$0	$0
Matt Peek	Director (Until Apr '24)	1.00	Director	$0	$0	$0
Barry Cole	Director	1.00	Director	$0	$0	$0
Dr Sam Zand	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$296,353	$191,808	$113,897	$104,545

Nevada Coalition for Psychedelic Medicines